Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 68, Issue 2, 2010, Pages 348-352

  Brown, Carlos V R ^a   Foulkrod, Kelli H ^a   Lopez, Daniel ^a   Stokes, John ^b   Villareal, Jesus ^a   Foarde, Katie ^a   Curry, Eardie ^b   Coopwood, Ben ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University Medical Center Brackenridge   (United States)

Author keywords

Coagulopathy; Craniotomy; Factor VIIa; Traumatic brain injury

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLUNT TRAUMA; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRANIOTOMY; DRUG EFFICACY; ERYTHROCYTE; FEMALE; HUMAN; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOEMBOLISM;

ADULT; AGED; BLOOD COAGULATION DISORDERS; BRAIN INJURIES; CRANIOTOMY; EMERGENCY MEDICAL SERVICES; FACTOR VIIA; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; WOUNDS, NONPENETRATING;

EID: 77249127036     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181bbfb6b     Document Type: Article

References (20)

1. Hedner U, Kisiel W. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. J Clin Invest. 1983;71: 1836-1844.
2. The United States Food and Drug Administration. The Center for Drug Evaluation and Research Page. Available at: http://www.fda.gov/cber/ label/novosevenrtLB.pdf. Accessed May 1, 2009.
3. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet. 1999;354:1879.
4. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51: 431-438.
5. O'Neill PA, Bluth M, Gloster ES. Successful use of recombinant factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma. 2002;52:400-405.
6. Martinowitz U, Kenet G, Lubetski A, et al. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth. 2002;49:S15-S20.
7. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth. 2003;15:184-188.
8. Boffard KD, Riou B, Warren B, et al.; NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebocontrolled, double-blind clinical trials. J Trauma. 1005;59:8-15.
9. Mayer SA, Brun NC, Begtrup K, et al.; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
10. Mayer SA, Brun NC, Begtrup K, et al.; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137.
11. Bartal C, Freedman J, Bowman K, Cusimano M. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. J Trauma. 2007;63:725-732.
12. Stein DM, Dutton RP, Kramer ME, Handley C, Scalea TM. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma. 2008;64:620-628.
13. Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma. 2009;66:63-75.
14. Narayan RK, Maas AIR, Marshall LF, Servadei F, Skolnick BE, Tillinger MN; rFVIIa Traumatic ICH Study Group. Recombinant factor VIIa in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery. 2008;62:776-786.
15. Stein DM, Dutton RP, Hess JR, Scalea TM. Low-dose recombinant factor VIIa for trauma patients with coagulopathy. Injury. 2008;39:1054-1061.
16. Ivascu FA, Howells GA, Junn FS, Bair HA, Bendick PJ, Janczyk RJ. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma. 2005;59:1131-1139.
17. Ilyas C, Beyer GM, Dutton RP, Scalea TM, Hess JR. Recombinant factor VIIa for warfarin-associated intracranial bleeding. J Clin Anesth. 2008;20:276-279.
18. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295:293-298.
19. Thomas GOR, Dutton RP, Hemlock B, et al. Thromboembolic complications associated with factor VIIa administration. J Trauma. 2007;62: 564-569.
20. Kluger Y, Riou B, Rossaint R, et al. Safety of rFVIIa in hemodynamically instable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebocontrolled, double blind clinical trial. Crit Care. 2007;11:R85.